Iris Unito Prodmetadata only
Daratumumab in combination with GDP chemotherapy in CD38-positive relapsed/refractory peripheral T-cell lymphoma: a phase 2 study of the Fondazione Italiana Linfomi
cd38, daratumumab, gdp, ptcl, relapsed/refractory, t-cell lymphoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 458502
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.